Paulo M. Hoff

机构：Instituto do Câncer do Estado de São Paulo, Translational Research in Oncology · ORCID：0000-0002-0065-2194

发表论文 547 篇 · 总被引 25907 次 · h-index 67

代表论文

• Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial (2022 · Gastric Cancer · 被引 60)
• Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study (2025 · Journal of Clinical Oncology · 被引 47)
• Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study (2025 · The Breast · 被引 24)
• Long-term outcomes of neoadjuvant immunotherapy plus chemotherapy in patients with early-stage triple-negative breast cancer: an extracted individual patient data and trial-level meta-analysis (2023 · British Journal of Cancer · 被引 20)
• Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer (2024 · npj Breast Cancer · 被引 10)
• INTRAPERITONEAL CHEMOTHERAPY FOR GASTRIC CANCER WITH PERITONEAL CARCINOMATOSIS: STUDY PROTOCOL OF A PHASE II TRIAL (2023 · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · 被引 8)